MYBPC1
Myosin-binding protein C, slow-type
Also known as: MYPC1_HUMAN, ssMyBP-C
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q00872
- Gene
- MYBPC1
- Ensembl
- ENSG00000196091
- Chromosome
- 12
- Canonical length
- 1141 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a member of the myosin-binding protein C family. Myosin-binding protein C family members are myosin-associated proteins found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. The encoded protein is the slow skeletal muscle isoform of myosin-binding protein C and plays an important role in muscle contraction by recruiting muscle-type creatine kinase to myosin filaments. Mutations in this gene are associated with distal arthrogryposis type I. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
1141 residues, UniProt reviewed canonical sequence.
>Q00872|MYBPC1
1 MPEPTKKEEN EVPAPAPPPE EPSKEKEAGT TPAKDWTLVE TPPGEEQAKQ NANSQLSILF
61 IEKPQGGTVK VGEDITFIAK VKAEDLLRKP TIKWFKGKWM DLASKAGKHL QLKETFERHS
121 RVYTFEMQII KAKDNFAGNY RCEVTYKDKF DSCSFDLEVH ESTGTTPNID IRSAFKRSGE
181 GQEDAGELDF SGLLKRREVK QQEEEPQVDV WELLKNAKPS EYEKIAFQYG ITDLRGMLKR
241 LKRMRREEKK SAAFAKILDP AYQVDKGGRV RFVVELADPK LEVKWYKNGQ EIRPSTKYIF
301 EHKGCQRILF INNCQMTDDS EYYVTAGDEK CSTELFVREP PIMVTKQLED TTAYCGERVE
361 LECEVSEDDA NVKWFKNGEE IIPGPKSRYR IRVEGKKHIL IIEGATKADA AEYSVMTTGG
421 QSSAKLSVDL KPLKILTPLT DQTVNLGKEI CLKCEISENI PGKWTKNGLP VQESDRLKVV
481 HKGRIHKLVI ANALTEDEGD YVFAPDAYNV TLPAKVHVID PPKIILDGLD ADNTVTVIAG
541 NKLRLEIPIS GEPPPKAMWS RGDKAIMEGS GRIRTESYPD SSTLVIDIAE RDDSGVYHIN
601 LKNEAGEAHA SIKVKVVDFP DPPVAPTVTE VGDDWCIMNW EPPAYDGGSP ILGYFIERKK
661 KQSSRWMRLN FDLCKETTFE PKKMIEGVAY EVRIFAVNAI GISKPSMPSR PFVPLAVTSP
721 PTLLTVDSVT DTTVTMRWRP PDHIGAAGLD GYVLEYCFEG STSAKQSDEN GEAAYDLPAE
781 DWIVANKDLI DKTKFTITGL PTDAKIFVRV KAVNAAGASE PKYYSQPILV KEIIEPPKIR
841 IPRHLKQTYI RRVGEAVNLV IPFQGKPRPE LTWKKDGAEI DKNQINIRNS ETDTIIFIRK
901 AERSHSGKYD LQVKVDKFVE TASIDIQIID RPGPPQIVKI EDVWGENVAL TWTPPKDDGN
961 AAITGYTIQK ADKKSMEWFT VIEHYHRTSA TITELVIGNE YYFRVFSENM CGLSEDATMT
1021 KESAVIARDG KIYKNPVYED FDFSEAPMFT QPLVNTYAIA GYNATLNCSV RGNPKPKITW
1081 MKNKVAIVDD PRYRMFSNQG VCTLEIRKPS PYDGGTYCCK AVNDLGTVEI ECKLEVKVIA
1141 QLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MYBPC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 10,574 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 10,574 nTPM
- tongue: 4,864 nTPM
- midbrain: 90 nTPM
- esophagus: 89 nTPM
- prostate: 78 nTPM
- breast: 60 nTPM
Single-cell type
- myonuclei: 14,831 nCPM
- thymic myoid cells: 5,551 nCPM
- prostatic glandular cells: 1,013 nCPM
- breast hormone-responsive cells: 511 nCPM
- prostatic club cells: 477 nCPM
- salivary acinar cells: 144 nCPM
Immune cell
- intermediate monocyte: 0.1 nTPM
- myeloid DC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- thalamus: 72 nTPM
- basal ganglia: 67 nTPM
- midbrain: 65 nTPM
- cerebellum: 55 nTPM
- hypothalamus: 54 nTPM
- amygdala: 45 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MYBPC1.
Disease | AllUniProt
Conditions MYBPC1 is implicated in, by any mechanism.
- Arthrogryposis, distal, 1B (DA1B) MIM:614335
- Lethal congenital contracture syndrome 4 (LCCS4) MIM:614915
- Congenital myopathy 16 (CMYO16) MIM:618524
Disease | GeneticClinVar
16 pathogenic / likely-pathogenic of 461 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Myopathy, congenital, with tremor
- Arthrogryposis, distal, type 1B
- MYBPC1-related disorder
- Distal arthrogryposis
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.02
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- MyBP-C, tri-helix bundle domain
- Striated Muscle Structural and Regulatory Protein
- Fibronectin type III domain
- Immunoglobulin I-set domain
- Tri-helix bundle domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MYBPC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MYBPC1 as an antibody target. Whether an autoantibody or antibody against MYBPC1 could matter depends on whether native MYBPC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MYBPC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MYBPC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...